To explore how the abundance of phosphorylated tau epitopes develop over the course of AD, CSF samples from two large cohorts were analyzed: TRIAD (n = 165) and BioFINDER-2 (n = 563). This evidence concerns the gene MAPT and Alzheimer disease.